Laboratorios Richmond SACIF (RICHm)

Currency in ARS
1,360.000
+10.000(+0.74%)
Closed·
RICHm Scorecard
Full Analysis
Operates with a significant debt burden
RICHm is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,335.0001,375.000
52 wk Range
887.0002,160.000
Key Statistics
Bid/Ask
1,335.00 / 1,380.00
Prev. Close
1,360
Open
1,350
Day's Range
1,335-1,375
52 wk Range
887-2,160
Volume
3.15K
Average Volume (3m)
12.18K
1-Year Change
46.24%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RICHm Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Laboratorios Richmond SACIF Company Profile

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is headquartered in Buenos Aires, Argentina.

Employees
620
Market
Argentina

Compare RICHm to Peers and Sector

Metrics to compare
RICHm
Peers
Sector
Relationship
P/E Ratio
5.8x11.6x−0.5x
PEG Ratio
0.020.020.00
Price/Book
1.5x1.7x2.6x
Price / LTM Sales
1.1x1.5x3.2x
Upside (Analyst Target)
-10.8%42.7%
Fair Value Upside
Unlock8.4%5.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 232.64%
Dividend Yield
1.98%
Industry Median 2.83%
Annualised payout
26.89
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 09, 2025
EPS / Forecast
70.15 / --
Revenue / Forecast
27.02B / --
EPS Revisions
Last 90 days

RICHm Income Statement

People Also Watch

48.68
ERJ
-0.59%
6.310
ITUB
-1.25%
617.000
TXARm
-2.22%
3,520.000
PAMPm
-1.81%
2,090.000
CGPA2m
-3.02%

FAQ

What Stock Exchange Does Laboratorios Richmond Trade On?

Laboratorios Richmond is listed and trades on the Buenos Aires Stock Exchange stock exchange.

What Is the Stock Symbol for Laboratorios Richmond?

The stock symbol for Laboratorios Richmond is "RICHm."

What Is the Laboratorios Richmond Market Cap?

As of today, Laboratorios Richmond market cap is 109.82B.

What Is Laboratorios Richmond's Earnings Per Share (TTM)?

The Laboratorios Richmond EPS (TTM) is 232.64.

From a Technical Analysis Perspective, Is RICHm a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Laboratorios Richmond Stock Split?

Laboratorios Richmond has split 0 times.

How Many Employees Does Laboratorios Richmond Have?

Laboratorios Richmond has 620 employees.

What is the current trading status of Laboratorios Richmond (RICHm)?

As of 23 Jul 2025, Laboratorios Richmond (RICHm) is trading at a price of 1,360.00, with a previous close of 1,360.00. The stock has fluctuated within a day range of 1,335.00 to 1,375.00, while its 52-week range spans from 887.00 to 2,160.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.